Short Interest in Jaguar Health, Inc. (NASDAQ:JAGX) Expands By 43.1%

Jaguar Health, Inc. (NASDAQ:JAGX) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 51,100 shares, a growth of 43.1% from the March 15th total of 35,700 shares. Based on an average daily volume of 24,800 shares, the days-to-cover ratio is presently 2.1 days. Currently, 9.2% of the shares of the stock are short sold.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Jaguar Health in a research report on Friday, March 28th. They set a “sell” rating on the stock.

Institutional Trading of Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC bought a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent SEC filing. Institutional investors own 12.04% of the company’s stock.

Jaguar Health Price Performance

NASDAQ JAGX traded down $0.10 on Friday, reaching $5.51. The company’s stock had a trading volume of 10,340 shares, compared to its average volume of 28,453. Jaguar Health has a twelve month low of $4.02 and a twelve month high of $540.00. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36. The firm’s 50 day moving average is $10.90 and its two-hundred day moving average is $20.54.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.